Olema Oncology to Participate in Upcoming Investor Conferences May 19, 2026 04:30PM
TD Cowen on Olema Pharmaceuticals (OLMA): 'Pala's Profile And Data Support Phase IIIs, Despite persevERA Disappointment' Mar 9, 2026 10:32AM
Olema Oncology announces public offering of common stock and warrants Nov 18, 2025 04:51PM
Olema Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants Nov 18, 2025 04:51PM
TD Cowen Reiterates Buy Rating on Olema Pharmaceuticals (OLMA) Nov 26, 2024 08:56AM


Jan 5, 2024 05:31PM Olema Pharmaceuticals (OLMA) Enters $150M ATM Agreement
Feb 22, 2023 06:11PM Today's most important initiations
Feb 21, 2023 04:30PM Olema Oncology to Participate at Upcoming Investor Conferences
Feb 28, 2022 04:30PM Olema Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Feb 22, 2022 07:30AM Olema Oncology to Present at Cowen 42nd Annual Health Care Conference
Dec 6, 2021 04:08PM Cowen Assumes Olema Pharmaceuticals (OLMA) at Outperform
Feb 23, 2021 07:00AM Olema Oncology to Participate at Upcoming Virtual Investor Conferences
Dec 14, 2020 06:36AM UPDATE: Cowen Starts Olema Pharmaceuticals (OLMA) at Outperform
Nov 23, 2020 04:01PM Olema Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Nov 19, 2020 11:07AM Olema Pharmaceuticals (OLMA) IPO Opens 137% Higher
Nov 19, 2020 06:27AM Olema Pharmaceuticals Inc. (OLMA) Prices 11M Share IPO at $19/Sh
Nov 18, 2020 08:10PM Olema Oncology Announces Pricing of Initial Public Offering